BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST
K-Number: K971349 · 1997-07-07
Advertisement
Device Summary
Frequently Asked Questions
What is the BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST?
BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST is a medical device that received FDA 510(k) clearance on 1997-07-07. The listed applicant is Princeton BioMeditech Corp.. The 510(k) number is K971349.
When did BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST receive FDA 510(k) clearance?
BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST received FDA 510(k) clearance on 1997-07-07, under 510(k) number K971349.
Who is the listed applicant for BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST?
The FDA 510(k) record lists Princeton BioMeditech Corp. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST?
The FDA product code for BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST is GTY.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Princeton BioMeditech Corp. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GTY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement